Saama Launches AI Tool that Automates Data Quality Checks
Data quality co-pilot considered the first of its kind.
Saama, an artificial intelligence (AI) solutions provider, has introduced a data quality (DQ) co-pilot, a feature embedded directly into its Smart Data Quality (SDQ) tool, that quickly generates code for simple to complex, cross-domain data quality checks and tests them using generative artificial intelligence (GenAI). According to the company, the product has the potential to significantly accelerate clinical development by eliminating the need to manually program, test, and deploy data quality checks.
“Generative AI and its application in clinical data management is transforming our approach to the visualization and analysis of clinical trial data,” said Malaikannan Sankarasubbu, VP, AI Research, Saama. “The time and effort saved using Saama’s embedded DQ co-pilot is empowering clinical development by enabling faster trail setup and giving precious time back to data managers. This time can be used to support more studies and focus their talent on higher-value activities, all with the goal to get new treatments to patients more quickly.”
Reference: Saama Introduces Industry’s First Generative AI Tool to Automate Data Quality Checks. Saama. September 19, 2023. Accessed September 20, 2023. https://www.saama.com/news/saama-introduces-industrys-first-generative-ai-toolto-automate-data-quality-checks/
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
